相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lack of Mitogen-Activated Protein Kinase Phosphatase-1 Protects ApoE-Null Mice Against Atherosclerosis
Jianzhong Shen et al.
CIRCULATION RESEARCH (2010)
MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy
Hao Shi et al.
FASEB JOURNAL (2010)
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels
Satoshi Imaizumi et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Switch from Stress Response to Homeobox Transcription Factors in Adipose Tissue After Profound Fat Loss
Simon N. Dankel et al.
PLOS ONE (2010)
Role of MKP-1 in Osteoclasts and Bone Homeostasis
Jodi Carlson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
MKP-1 Is Necessary for T Cell Activation and Function
Yongliang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
Rachel J. Roth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis
Mustafa Zakkar et al.
CIRCULATION RESEARCH (2008)
Toward a Molecular Understanding of the Interaction of Dual Specificity Phosphatases with Substrates: Insights from Structure-Based Modeling and High Throughput Screening
Ahmet Bakan et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3′,5′-cyclic adenosine 5′-monophosphate response element-binding protein and the generation of reactive oxygen species
Robert Fuerst et al.
ENDOCRINOLOGY (2008)
Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling
Wangsen Cao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
MKP-1 mRNA stabilization and translational control by RNA-Binding proteins HuR and NF90
Yuki Kuwano et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The role of exercise and PGC1α in inflammation and chronic disease
Christoph Handschin et al.
NATURE (2008)
Mitogen-activated protein (MAP) Kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer
Tarek Boutros et al.
PHARMACOLOGICAL REVIEWS (2008)
Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance
Brice Emanuelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids
Jana V. Maier et al.
MOLECULAR ENDOCRINOLOGY (2007)
Mechanisms of specificity in protein phosphorylation (vol 8, pg 530, 2007)
Jeffrey A. Ubersax et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Modulation of PPAR activity via phosphorylation
Katherine A. Burns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Mechanisms of specificity in protein phosphorylation
Jeffrey A. Ubersax et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
D. M. Owens et al.
ONCOGENE (2007)
Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5
Xiao Tao et al.
PROTEIN SCIENCE (2007)
p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis
Yan Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Feedback control of MKP-1 expression by p38
Jun-Hao Hu et al.
CELLULAR SIGNALLING (2007)
MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium
Robert Fuerst et al.
FASEB JOURNAL (2007)
The JNK signal transduction pathway
Claire R. Weston et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy hemeostasis, and metabolism
Christoph Handschin et al.
ENDOCRINE REVIEWS (2006)
Dual-specificity phosphatase 1: a critical regulator of innate immune responses
S. M. Abraham et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Spatio-temporal regulation of mitogen-activated protein kinase (MAPK) signalling by protein phosphatases
M. Karlsson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1
John S. Lazo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: Structural insight into constitutively active phosphatase
Dae Gwin Jeong et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity
J. Julie Wu et al.
CELL METABOLISM (2006)
Macrophage-colony-stimulating factor-induced proliferation and lipopolysaccharide-dependent activation of macrophages requires Raf-1 phosphorylation phosphatase-1 expression
Ester Sanchez-Tillo et al.
JOURNAL OF IMMUNOLOGY (2006)
Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses
HB Chi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Essential role of MAPK phosphatase-1 in the negative control of innate immune responses
KV Salojin et al.
JOURNAL OF IMMUNOLOGY (2006)
Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock
M Hammer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock
Q Zhao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling
YW Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells
HY Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation
JJ Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The benzo[c] phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1
A Vogt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling
JJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases
H Kamata et al.
CELL (2005)
The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis
F Bost et al.
DIABETES (2005)
The role of MAPKs in adipocyte differentiation and obesity
F Bost et al.
BIOCHIMIE (2005)
Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter
S Ryser et al.
BIOCHEMICAL JOURNAL (2004)
Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation
H Sakaue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models
ST Reddy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
JNK: a new therapeutic target for diabetes
BL Bennett et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Targeting JNK for therapeutic benefit: From JuNK to gold?
AM Manning et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation
R Somwar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages
PL Chen et al.
JOURNAL OF IMMUNOLOGY (2002)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38
M Lasa et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1
O Kassel et al.
EMBO JOURNAL (2001)
p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor α -: A potential role in the cardiac metabolic stress response
PM Barger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1
P Puigserver et al.
MOLECULAR CELL (2001)
Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity
J He et al.
DIABETES (2001)
Signaling networks: The origins of cellular multitasking
JD Jordan et al.
CELL (2000)
A conserved docking motif in MAP kinases common to substrates, activators and regulators
T Tanoue et al.
NATURE CELL BIOLOGY (2000)
分享论文
